| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 10/13/2004 | EP1465869A1 Modulators of lxr |
| 10/13/2004 | EP1465864A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 10/13/2004 | EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
| 10/13/2004 | EP1465638A2 Phosphate transport inhibitors |
| 10/13/2004 | EP1465632A1 Quinazoline derivatives for the treatment of abnormal cell growth |
| 10/13/2004 | EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/13/2004 | EP1465630A1 Cyclic urea derivatives with 5-ht2c receptor activity |
| 10/13/2004 | EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 10/13/2004 | EP1280797B1 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1268472B1 3-aminopyrazole inhibitors of cyclin dependent kinases |
| 10/13/2004 | EP1097142B1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537102A Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 10/13/2004 | CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 10/13/2004 | CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound |
| 10/13/2004 | CN1170827C Benzofurylpyrone deriuvatives |
| 10/13/2004 | CN1170819C Piperidine alcohols |
| 10/13/2004 | CN1170584C Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives |
| 10/13/2004 | CN1170538C Farnesyl protein transferase inhibitors for treating arthropathies |
| 10/12/2004 | USRE38624 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation |
| 10/12/2004 | US6803381 Carbamic acid derivatives |
| 10/12/2004 | US6803374 Compounds useful for treating hepatitis C virus |
| 10/12/2004 | US6803129 Organic light emitting diode and organic luminescent materials thereof |
| 10/12/2004 | CA2170394C Process for conditioning substances |
| 10/07/2004 | WO2004085434A1 Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
| 10/07/2004 | WO2004085433A2 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 10/07/2004 | WO2004085425A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors |
| 10/07/2004 | WO2004085414A1 Process to produce enantiomerically enriched 1-aryl- and 1-heteroaryl-2-aminoethanols |
| 10/07/2004 | WO2004085408A1 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 10/07/2004 | WO2004085401A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/07/2004 | WO2004085399A1 Oxamide derivatives useful as raf-kinase inhibitors |
| 10/07/2004 | WO2004085384A2 Bis-aryl sulfonamides |
| 10/07/2004 | WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | WO2004084843A2 Inhibitors of cathepsin s |
| 10/07/2004 | WO2004084813A2 Chemical compounds |
| 10/07/2004 | WO2004084634A1 N-phenyl- ‘ (4-pyridyl)- azinyl!amine derivatives as plant protection agents |
| 10/07/2004 | WO2004060362B1 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β |
| 10/07/2004 | WO2004026829A3 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibitors |
| 10/07/2004 | US20040198987 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use |
| 10/07/2004 | US20040198984 1-(3-halopyrid-2-yl)-3-substituted-5-((2,4-substituted-6-aminocarbonyl)phenylaminocarbonyl) pyrazoles insecticides |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198787 Efficient process for the preparation of a factor Xa inhibitor |
| 10/07/2004 | US20040198786 Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198773 Anticancer agents |
| 10/07/2004 | US20040198771 medical equipment for angioplasty |
| 10/07/2004 | US20040198742 Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use |
| 10/07/2004 | US20040198739 Prevention reproduction of virus |
| 10/07/2004 | US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents |
| 10/07/2004 | US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders |
| 10/07/2004 | US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 10/07/2004 | CA2520440A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | CA2520405A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/07/2004 | CA2520055A1 Process to produce enantiomerically enriched 1-aryl- and 1-heteroaryl-2-aminoethanols |
| 10/07/2004 | CA2520009A1 Oxamide derivatives useful as raf-kinase inhibitors |
| 10/07/2004 | CA2519288A1 N-phenyl-[(4-pyridyl)- azinyl]amine derivatives as plant protection agents |
| 10/07/2004 | CA2519265A1 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 10/07/2004 | CA2519053A1 Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
| 10/07/2004 | CA2518909A1 Heterocyclic compounds and methods of use |
| 10/07/2004 | CA2505590A1 Bis-aryl sulfonamides |
| 10/06/2004 | EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist |
| 10/06/2004 | EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463713A1 Prodrugs of excitatory amino acids |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1301509B1 Multifunctional coupling agents with cyclic iminoester and iminoether groups, method for producing the same and use thereof |
| 10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/06/2004 | EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors |
| 10/06/2004 | EP0970070B1 Phthalazines with angiogenesis inhibiting activity |
| 10/06/2004 | CN1535266A Dihydro-benzo [b][1,4] diazepin-2-one derivatives as mglur 2 antagonists II |
| 10/06/2004 | CN1535151A Novel anti-infectives |
| 10/06/2004 | CN1169798C Novel diazo alcoholic antifungal compound and its preparing process |
| 10/06/2004 | CN1169797C Antiviral phrimidinedione derivatives and process for preparation thereof |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | US6800645 Substituted azabicyclic compounds |
| 10/05/2004 | US6800630 Cytostatic activity, inhibitory activity against a signal derived from ras oncogene products |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 09/30/2004 | WO2004083206A1 Antibacterial oxalidinones |
| 09/30/2004 | WO2004083205A1 Antibacterial 1, 3- oxazolidin -2- one derivatives |
| 09/30/2004 | WO2004083187A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2004083182A1 Cathepsin s inhibitors |
| 09/30/2004 | WO2004083174A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 09/30/2004 | WO2004083173A2 Ketopiperazine derivatives as bradykinin antagonists |
| 09/30/2004 | WO2004082687A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
| 09/30/2004 | WO2004082638A2 Histone deacetylase inhibitors |
| 09/30/2004 | WO2004082623A2 Substituted piperidine compounds |
| 09/30/2004 | WO2004082602A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2004043349A3 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 09/30/2004 | WO2004041209A3 Transcription factor modulating compounds and methods of use thereof |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
| 09/30/2004 | US20040192779 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
| 09/30/2004 | US20040192753 Methods of use of thrombin receptor antagonists |
| 09/30/2004 | US20040192752 Anti-HIV pyrazole derivatives |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192743 Substituted azole derivatives as therapeutic agents |